Neoadjuvant treatment for intermediate/high-risk HER2-positive and triple-negative breast cancers: no longer an ‘option’ but an ethical obligation
-
Published:2019
Issue:3
Volume:4
Page:e000515
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Brandão MarianaORCID,
Reyal FabienORCID,
Hamy Anne-SophieORCID,
Piccart-Gebhart Martine
Subject
Cancer Research,Oncology
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献